Loblaw Companies Ltd
TSX:L
Earnings Call Analysis
Q4-2023 Analysis
Loblaw Companies Ltd
The company reflected positively on its most recent quarter, highlighting ongoing top-line sales growth and market share momentum even against a backdrop of challenging inflationary pressures. Particularly noteworthy is how the company's Food business has continued to grow despite already high same-store sales from the previous year. This performance is credited to a relentless pursuit of delivering value to customers, including leveraging control brands, personalized offers, and expansion of hard discount stores. A commitment to providing customers with affordable options in light of persistent inflation is clear; internal inflation within the company has remained below the Consumer Price Index (CPI), and they have actively been working to minimize cost increases from suppliers.
The pharmacy division of the company has lapped strong results thanks to continued growth in beauty product sales and the cough and cold category. Front-store sales at the company's pharmacies indicate a positive customer response, backed by over 2,100 pharmacies and clinics, and a health app. Particularly, the company has provided a significant amount of prescribing services, thus contributing to healthcare access. The plan to expand with over 140 clinics signifies confidence in the growth of this segment.
Digital strategies have been a focus area for the company, with significant investments in personalization platforms and loyalty programs. The company reports record levels of digital customer engagement, particularly through PC Optimum loyalty points, which increased the share of customer wallet. The company intends to further capitalize on this by increasing digital engagement and providing more value through its platforms, expecting a double-digit increase in weekly active users in 2023 and further growth in 2024.
The company has detailed plans for capital investments aimed at enhancing its network across communities with an emphasis on affordable food and healthcare access. This includes a $2.2 billion reinvestment plan for 2024, adding to a significant amount already invested since 2016. Additionally, the company has also made progress in environmental, social, and governance (ESG) fronts, particularly in reducing plastic waste and food waste, aligning with its stated goals and commitments.
Careful attention is advised when interpreting financial numbers due to the impact of high inflation in the previous year's comparisons. The company anticipates continued efforts will pay off, allowing them to deliver on their financial framework and express expectations to return a significant portion of their excess free cash flow to shareholders. Interestingly, growth in the 'Freight as a Service' business could also contribute to financial outcomes.
While the overall organization's performance is more or less flat, the company states it is gaining market share in the discount segment and holding its own in conventional markets versus its peers. The e-commerce segment has shown increased penetration and growth primarily in food delivery, reflecting consumer behavior adjustments in response to market dynamics. There is a 60% pickup and 40% delivery split in e-commerce currently.
Shoppers Drug Mart continues to play a significant role in the company's overall performance, representing a mid-40s percentage of retail EBITDA. Recent growth drivers include specialty drugs that command high average values, yet are constrained by supply limitations. This has emerged as a new and promising phenomenon contributing to the company's comps, with specific mention of Ozempic shortages pointing to the demand for these specialty drugs.
You don't have any saved screeners yet
Good morning, ladies and gentlemen, and welcome to the Loblaw Companies Limited Fourth Quarter 2023 Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, February 22, 2024.
I would now like to turn the conference over to Mr. Roy MacDonald. Please go ahead, sir.
Thank you, Cinthu, and good morning, everybody. Welcome to the Loblaw Companies Limited Fourth Quarter and Full Year 2023 Results Conference Call. I am happy to be joined here this morning by Per Bank, our President and Chief Executive Officer; and by Richard Dufresne, our Chief Financial Officer.
So before we begin the call, I want to remind you that today's discussion will include forward-looking statements, which may but are not limited to statements with respect to Loblaw's anticipated future results and these statements are based on assumptions and reflect management's current expectations, as such, are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from our expectations.
These risks and uncertainties are discussed in the company's materials filed with the Canadian securities regulators. Any forward-looking statements speak only as of the date they are made. The company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, other than what's required by law.
Also, certain non-GAAP financial measures may be discussed or referred to today. So please refer to our annual report and other materials filed with the Canadian securities regulators for a reconciliation of each of these measures to the most directly comparable GAAP financial measure.
And with that, I'll turn the call over to Richard.
Thank you, Roy, and good morning, everyone. We are very pleased to deliver another year of consistent operational and financial results. Our businesses continue to perform well, reflecting our focus on retail excellence. On the full year, revenue came in at just under $60 billion, and we generated earnings in excess of $2 billion. We plan to reinvest over $2 billion back into the Canadian economy and in jobs through our 2024 capital program.
Turning to the quarter. I'm especially pleased with our performance, given that we are lapping an extremely strong Q4 last year when sales grew almost 10%, EBITDA increased by double digits and EPS grew 16%. We accomplished this by remaining focused on delivering value to consumers, carefully managing our expenses and continuing to invest for the future.
On a consolidated basis, revenue grew by 3.7%, and EBITDA increased by 9.4%. Adjusted diluted net earnings per share grew by 13.6% to $2 per share. On a GAAP basis, our net earnings available to common shareholders grew by 2.3%. In drug retail, absolute sales increased 4.9% and same-store sales grew 4.6%. Front store performance exceeded our own expectations this quarter given our strong performance in Q4 last year.
Front store same-store sales grew by 1.7%, while lapping growth of 11.5% last year. Cosmetics and health and beauty continue to deliver very strong results. OTC sales remained strong. Overall, we are very pleased with the ongoing strength of our front store business. Pharmacy and Healthcare services same-store sales grew by 8%, driven by growth in acute and chronic prescriptions, including, including continued strength in specialty drugs. At the same time, we're pleased with the growth of services related to expanded scope of practice. These services doubled in the quarter compared to last year.
In Food Retail, absolute sales increased 2.7% and same-store sales grew 2%, again last -- against last year same-store sales growth of 8.4%. Our offers are resonating well with customers demonstrated by higher traffic and continued market share momentum. Our leading hard discount grocery banners outperformed in Q4 and lead our performance, bringing value to Canadians at a time of heightened cost of living pressure.
Our internal food inflation was significantly lower than CPI again this quarter. This clearly demonstrates the role we are playing to help stabilize food prices for our customers. In Q4, our average item price increase was the lowest it has been in more than 2 years. Loblaw continued to leverage its strength to bring value to our customers. The strength of our discount offering across the country is evident as consumers continue to migrate their shop to hard discount stores.
In Quebec, we have converted 24 Provigo stores to Maxi and plan to convert another 30 stores this year. We believe the outperformance of our hard discount stores will continue as Canadians seek value to help manage through the challenges of this extended period of economic uncertainty. Although discount continues to outperform conventional grocery, our market banners remain very healthy, and we are pleased with our performance, having the right customer offer in all our stores remains a key focus.
Right-hand side had a negative impact on same-store sales of 80 basis points again this quarter. These categories remain accretive to our gross margin as we continue to carefully manage inventory levels. Online sales in the quarter increased 14.6% and exceeded $3.3 billion on a full year basis. We continue to enhance our customer experience and differentiate ourselves by offering more choice and flexibility. Delivery continues to outperform as a channel.
Total retail gross margin was 31.1%, in line with our full year rate of 31%. In Q4, our margin was up 50 basis points as we lapped a decline of 30 basis points last year. This reflects sequential shrink momentum and initiatives such as our freight business which allow us to invest in value while delivering stable margin performance.
Turning to SG&A. Our spend rate as a percentage of sales increased 10 basis points and included a number of onetime costs this quarter that offset our operating leverage. We finalized 2 important labor agreements in the quarter, which will benefit over 24,000 colleagues and bring certainty to our costs and operations. With these agreements in place, we do not have another major labor contract up for negotiation until the second half of 2026.
Adjusted retail EBITDA increased by $114 million, yielding a margin of 10.8%, up 40 basis points compared to last year. This quarter saw strong performance at the bank. PC Financial's revenues increased 16.8% driven by growth in the credit card portfolio, supported by an increase in customer spending and higher mobile shop sales.
Adjusted earnings before tax increased 45.5% with higher interest income and lower operating costs, partly offset by higher credit losses and loss provisions. We remain very comfortable with the risk profile of our portfolio. We have a strong and well-capitalized balance sheet, and we continue to take a conservative position in our provisioning.
On a consolidated basis, adjusted EBITDA margin was 11.2% in the quarter, up 50 basis points compared to last year. Our retail free cash flow was $512 million, and we repurchased $494 million worth of common shares in the quarter.
On a full year basis, our retail free cash flow was $1.7 billion, and we repurchased $1.8 billion worth of common shares. We invested approximately $2.1 billion in CapEx, and our free cash flow generation continues to be very strong, as demonstrated again in 2023. Our balance sheet remains strong, and we continue to improve our key return metrics. Our return on equity sits at 22.2% and our return on capital at 11.5%.
Looking ahead to 2024, we have a solid plan in place to continue to deliver consistent financial and operational performance while advancing our growth initiatives. This will allow us to continue to deliver value to our customers and to our shareholders. Specifically, we are accelerating our opening of new stores. We plan to open over 40 new stores in 2024 and convert another 30 stores to discount. Our real estate strategy is working.
For the full year 2024, we expect our retail business to grow earnings faster than sales and adjusted earnings per share growth in the high single digits. We plan to invest approximately $2.2 billion in capital expenditures or $1.1 billion net of proceeds from planned property disposal. Again, we plan to return most of our strong retail free cash flow to shareholders through dividends and share buybacks. We begin the new year confidently as we are carrying our Q4 momentum into Q1.
I will now turn the call over to Per.
Thank you, Richard, and good morning, everyone. This is my first analyst call since joining the organization as CEO. It has been an exciting time for me, and I have been looking forward to sharing my thoughts and our progress with you. From my perspective, the past several months have been amazing. I traveled the country, talking to customers, visiting colleagues, suppliers, investors and other important stakeholders. I have learned so much about Canadian customers and about the Loblaw business.
Two things have really struck me during my travels. First, at Loblaw, we have a unique and very special relationship with our customers, in fact, with most Canadians. This means that they have higher expectations of us. Customers are increasingly rewarding us with their business, but they're also not shy about letting us know when we can do things better.
Secondly, Loblaw has tremendous strength in the commitment, diversity and experience of our team coast-to-coast. Together, we are executing well across our business and have an excellent foundation to build upon, including the great asset and proven strategies we are pursuing to drive consistent growth and performance. Our focus remains on our strategic pillars of retail excellence, driving growth and investing in the future, while at the same time, embedding ESG into everything that we do.
Turning to the quarter. I'm very pleased with our results. We experienced continued market share momentum and top line sales growth against a very strong Q4 last year. In our Food business, we lapped very strong same-store sales and drove further growth, increasingly Canadians are looking for and rewarding value.
In my view, Loblaw is better positioned than any other food retailer to deliver value. One of our focus areas is to relentlessly pursue new opportunities to unlock value and respond to customers' needs. To illustrate, we continue to lever our leading control brands, promotional activity and personalized PC Optimum offers. We're also expanding our hard discount Maxi and No Frills store by opening 31 hard discount locations last year alone.
Our recently announced Hit of the Month campaign is a great demonstration of our unique ability to appeal to Canadians, and our commitment to provide them with unmatched value offering on some key everyday products across our banners. Customers response to this program has been terrific. We're in the early days of this program, and there are more exciting things to come. Canadians continue to see greater value as they face challenging and persistent inflationary pressures, and we are committed to delivering that. Once again, our internal inflation was lower than growth of CPI, while our full gross margin is still below pre-COVID levels.
Food price increases in our stores are as low as they have been over the past 2 years. We are pushing back whenever we can on suppliers' cost increases, and we are finding ways -- more ways to be efficient to keep prices low for our customers. Our colleagues are doing a great job to reduce costs and be more efficient, allowing us to reinvest back into the business and help offset inflation. Our hard discount banners are outpacing the market, and we are well placed to benefit from the ongoing discounts and trade down effects. Our market banners continue to perform well. These stores are being refocused on value, and we are targeting our offers in a more meaningful way to our customers. We are pleased with the early results.
In pharmacy, we're also lapping very strong results from last year. Our continued positive same-store sales growth reflect the continued strength in front store beauty products and from strong store sales in cough and cold category. Customers continue to respond very positive to the convenience level -- the convenient and level of care we offer to our more than 2,100 pharmacies and clinics and over 20,000 health care professionals and our PC Health Interactive app. We have seen a very positive reaction across the country to our ability to deliver expanded scope of practice in our pharmacies, including our 74 new pharmacy-based clinics.
Our pharmacies provided 2.4 million prescribing services last year. Another way to think about it is that we freed up an additional 2.4 million appointment with doctors. This is important when wait times are long and many Canadians do not have a family doctor. We will continue to invest in this area with more than 140 new clinics already planned for this year.
Another area in which we are unlocking value is the digital domain. We are harnessing the combined strength of Loblaw digital loyalty in advance, and we are well positioned to create seamless and personalized experiences that enhance our customers' shopping journey and deliver exceptional value. In particular, we are investing in our personalization platform that will allow us to showcase the most appealing and relevant offers to our customers depending on their personal preferences.
Canadians continue to take advantage of PC Optimum loyalty points across our business and in record levels with increasing digital customer engagement, more meaningful personal offers and effective promotions. This high level of engagement PC Optimum enjoys greater loyalty for us and is resulting in increasing share of customer wallet.
Building on the leadership position of our loyalty program. We are working to increase digital engagement on our PC Optimum platform by providing our members greater value. To illustrate, we have seen a double-digit increase in weekly active users in 2023. Another area of growth is expansion of our reach. In 2024, we will continue to invest to update and expand our store network and distribution centers. This is part of our capital program, where we expect to reinvest a total of $2.2 billion back into communities across the country. This record investment reflects our commitment to enhancing the store network, creating job opportunities and improving access to affordable food and health care services for Canadians. This year investment in addition to more than $10 billion, the company has invested in since 2016.
I mentioned at the outset that Canadians have high expectations of Loblaw. We do a lot. But of course, we can always do better. One of the many ways we are working to live up to expectations and be a leader is our commitment to environmental, social and governance leadership. As a part of our overall ESG framework, we have 2 main pillars of advancing social equity and fighting climate change. I'm pleased to share that today, we have issued some early priority disclosures around these 2 pillars. This is in advance of our annual ESG report, which is scheduled to be issued in April. These pages, you'll read about some of the significant strides we have made on our ESG agenda. For example, in plastics, we've taken a leadership position to drive change across our industry. On our target to reduce plastic waste by ensuring all control brands and in-store plastic packaging a recycle or reusable by 2025. We have made excellent progress, achieving 64% compliance in 2023. We also made considerable progress in reducing our food waste. On our way to our target of zero food waste to landfill by 2030, 100% of our corporate stores are now partnered with food banks and other food recovery agencies, more than doubling our food donation rate in 2023 and moving us much closer to our zero waste target and our colleagues and customers to be particularly proud working together. Our PC Children Charity came very close to reaching its 2025 target of feeding 1 million Canadian children in schools across the country. Thank you for your ongoing support of this important initiative. I'm proud of this progress, and I look forward to future engagements with you on our ESG journey.
To sum up, we delivered another strong quarter to wrap up a very successful year. We opened and converted over 40 stores, expanded our scope of health care practice and greatly advanced our ESG initiatives. I'm proud of how our team is delivering retail excellence, creating value for our customers and our shareholders. I would like to extend a heartful thank to all of our colleagues for your pursuit of these goals every single day.
Entering the new year, our portfolio of businesses remain strong and well positioned to deliver for Canadians who are increasingly turning to us for value and service. Our core focus remains on delivering retail excellence, executing well across our operations and an unrelenting focus on our customers, which is what allows us to continue to invest in our business and in growth. Personally, I'm looking very much forward to working with the team and unlocking further value to drive growth across our business.
With that, I will open the call for any questions that you may have. Thank you.
Thank you, Per. Cinthu, if you'd go ahead and introduce the process for asking questions.
[Operator Instructions] Our first question comes from Mark Petrie from CIBC.
First, would you say the performance gap between discount and conventional sales growth is stable? Or is it expanding at this point?
It's about the same as we've seen over the last few quarters.
Okay. And I also wanted to ask about the dynamic that you're seeing in terms of the balance between national brands and control brands. Obviously, private label is a massive part of your sales and earnings base. They've been strong performers and outpacing national brands. I know there's a natural tension there that you're always managing, but I'm curious just to hear your perspectives, Per, I guess, just given your experience in Europe, the different dynamics there? And then what you've seen in Canada, not just at Loblaw, but in the market overall.
No, yes. I think that we haven't changed our strategy on pursuing our control brands. But when this is said, I do believe that we can believe that we can grow with both national brands and our control brands because like the Hit of the Month, there we are only doing the national brands because we think that we can tap in and help the national brands grow and hopefully also tap into the profit pool because they actually make a lot of money, and hopefully, they will support us in growing.
So it comes down to that. I think we can grow with both national brands and control brands at the same time to the benefit of our customers because many of our customers, they still want both control brands, and they also love some of the national brands.
Yes. Understood. Okay. And then Richard or maybe Per, what do you see as the drivers for neutralizing the right-hand side of the store as a headwind to the food same-store sales result. And do you think that could be an area of growth at some point? Or is it just a question of as you sort of said, managing inventory to preserve the gross margin?
Yes. No, it's a very good point. And when we talk about the right-hand side of the stores, we are talking about superstores only. And it is, of course, something that we are looking into. And -- we are talking about health and beauty. We are talking about nonfood, and we are talking about clothing. So -- so yes, it is something that's on our mind. It's something that we are working with. And of course, we would like to pursue some growth there. It's too early to reveal anything, but it's definitely on my mind to do even better at the right hand side of the store. And it is margin enhancing as well.
The next question comes from Irene Nattel from RBC Capital Markets.
You noted that your internal inflation was, I think, significantly is the word you used, Richard, below CPI. So how are you walking this line of continuing to invest in pricing, it sounds as though, to deliver value for consumers while simultaneously protecting the gross margin.
So I think we need to be careful, Irene, when we look at the numbers because like it's math. And if you look in Q4 last year, like we had comp sales in food that was north of 8%, inflation was running very high single digits. So we're lapping those numbers. So that is a factor. But when you look at our strategies, like we continue to do what's right to invest, to drive traffic to our stores, and that's what we're really focused on. The comp performance or the inflation is just an implicit number that comes out of all of this. But like you look at what we're doing now, like we're very happy with what's happening with our market share performance, specifically in discount. And so that tells us that our strategies are working.
That's very helpful. And can you talk about what you're seeing, we're hearing a lot from whether it's the other food retail or other retailers period or suppliers. What you're seeing in terms of consumer beat trade-down behavior? And sort of as you think about 2024, what your underlying expectations are on that side.
Yes. So for this year, I think we will see more of the same. So what we have seen last year is that customers, they are increasingly looking for value and they're doing it in 3 ways. So one, they are buying more into our promotions because that's a way of mitigating their own internal inflation. Two, they're buying more into the control brand, especially no name is really, really successful. And then thirdly, moving more to hard discount. So I think that's the 3 things that we will see more of this year as we saw last year.
Understood. And as we think about this consumer value-seeking behavior, can you talk about what you're seeing in front of shoppers where you have a larger component of discretionary spend.
No, yes. It's funny because when I speak to some of our beauty managers at Shoppers when I did my introduction. I was curious to see how customers are responding to beauty. A family, they buy fragrance for $100, actually customers, they don't care. It feels like it's not the same customer as we have in our grocery stores because in a grocery store, then $0.10 of a leaf of bread means so much to them. But we don't see the same in Shoppers. They are not as price sensitive and they buy all expensive beauty products. But when this is set, then when we discuss and we talk about our Hit of the Month product. So for example, Kraft Dinner at $0.55, it's also sold across all our Shoppers because we also want our customers in our Shoppers Drug Mart to have that feeler for value, especially in the grocery part. But it's kind of a different business.
And are you seeing -- last question, I promise. Are you seeing a step-up in redemption activity on those higher price point items at Shoppers?
We're seeing slightly higher redemption activity in total, Irene, like I actually don't -- I haven't looked at the specific of it. But like because customers have a tighter wallet, they're using their points more, and we're seeing -- we're definitely seeing that.
That's great. And love the LinkedIn post, by the way.
Our next question comes from George Doumet from Scotiabank.
Richard, I just wanted to hone in on the drivers of the high single-digit EPS growth that you're calling out for next year in terms of maybe goalpost for sales, gross margin and SG&A and buyback activity came in kind of ahead of expectations in '23, do you expect to buy back the same number of shares in '24?
Yes. So the drivers for '24 are going to look a lot like the drivers in '23. We expect gross margin to be more or less stable, okay? SG&A rate will be more or less stable because we're -- we have the labor cost pressures that everybody has been facing, but we put in place initiatives to offset -- to reduce cost to be able to manage those. And we are expecting a small tailwind from shrink. So together, these 3 things will allow us to deliver on our framework. And the answer to your last part of your question is, yes, we -- we expect to return again a significant portion of our excess free cash flow and the free cash flow should be more or less in line in '24 as it was in '23, so.
Great. And then it's probably a bit of a crystal ball question, but we saw a material deceleration food CPI in January. Just wondering when you think you can see maybe a more pronounced disinflation at the center of the store?
We're seeing it now, like our inflation. If you were to look at our inflation measurement, for -- by period because we look at it every month, like unlike where we report the quarter, it's actually been going down steadily since January 2023. And so the number we finished in December was lower than the average that we're reporting for the quarter. So inflation I'd say right now seems to be stabilizing, and it's still positive, but it's -- the next number we report should be lower than what we reported in Q4.
Okay. And just maybe one last one for Per. If you can talk a little bit about what you think of the long-term plans to grow square footage at the grocery side of the business. Just wondering Per where do you see the most run rate for growth.
No, I think it's too early to say. But clearly, you can see that we are stepping up in our new store growth already this year. So -- so we are paying attention to it and looking for opportunities, but more to come later on that.
The next question comes from Tamy Chen from BMO.
I wanted to talk about shrink at Shoppers. Richard, you briefly alluded to it in the previous question. But I believe you were expecting, and it sounds like you did see sequential improvement in the shrink this quarter versus Q3. And so can you talk a bit about where you stand now as you exited last year, like -- is the headwind really modest now and you're assuming that the first half of this year, you're going to largely get back to a normal level?
Yes. I think we are cautious positive on the shrink, and we are seeing that it's coming down since last quarter and we're entering into this year at the level where we want it to be, but it's something that we are paying really, really attention to, and we need to work hard to continue to reduce shrink and especially in Shoppers because that's where we have the most expensive products. And we have done a lot. So the teams have locked up a lot of products. We are looking at top 50 shrink stores and we're implementing gates, but we're paying a lot of attention to it because we know it's important to continue the trajectory that we offer of getting the shrink down. I don't know if you have anything, Richard.
No, I think that's good.
Okay. That's good to hear. Then some of the other pieces in the gross margin. So you mentioned freight as a service, and I think there's also been rebidding with vendors that has been a bit of a tailwind. Can you talk about those 2? Like were they quite meaningful in terms of tailwinds this quarter?
Freight as a service is starting to be meaningful, yes. So it's not a few basis points. It's more than that. And so this is a business that has grown quite significantly in 2023, and we are anticipating some, again, outsized growth in 2024 for that business.
And you should think as freight as a service, as we are helping our suppliers because they're only using us when they can get cheaper freight than elsewhere. So that's also a good thing for Canadians.
Okay. Got it. And my last question is on in Shoppers, the pharmacy comp. So like you said, it continues to be very strong on the expanded scope, I mean you've got -- you ended the year with a bit over 70 locations that have this, but it sounds like it's contributing quite a meaningful component to the comp. You alluded to 2.4 million appointments, which you did last year. Can you talk a bit about like what was it in 2022? Is that mostly skewed to Alberta. I think that's the most advanced province doing this, right? And so I just want a bit more color on the magnitude expanded scope had this quarter and your expectations going forward?
Yes, it was 0 in 2022. We started that last year. So this is a new initiative. And we're actually quite thrilled with what it's doing for us. So that's why like we have 70-plus clinics now and plan to open another 140 this year because we're seeing some great traction.
Yes. And we are continuing the momentum that we saw in Q4. So we feel confident.
The next question comes from Vishal Shreedhar from National Bank.
Per, I just want to talk about some of the recent management changes that were made, including the President of Discount taking over market. Does this signal changes in the market division focusing more on discount-oriented merchandising tactics, what should we take away from that change?
Thanks for the question. And for me, when I started my role here, it was a question because we had a discount division, consisting of our Real Canadian Superstore and then our hard discount. And for me, this is 2 completely different ways of approaching our customers because in a Superstores, you will have, whatever, 40,000, 50,000, 60,000 products available for customers. And it's like on 100,000 to 160,000 square feet. And in a discount store, it's much more limited space. It ranges from 10,000 to 35,000 square feet. So it's a different customer experience. It's a different way of trading.
So for me to get the most out of both our market and our superstores and hard discount, then I thought it was -- it gets absolutely sense to carve out our hard discount in 7 division led by Melanie Singh because I think we can get more out of it by doing it this way. Because I also want to really operate the hard discounters as hard discounters. And as customers that turn more into hard discount, I think it makes a lot of sense to have that separately.
And when I look at the market and Superstore division, now, for example, we have the Real Atlantic Superstores combined with the Real Canadian Superstore, so now we have a superstore banner coast to coast. We didn't have that before, meaning that we can utilize the strength of negotiating with suppliers and giving great promotion and great offers to customers across the country. And it's a more high low base as well. So there's so many similarities. And having Frank Gambioli running our market and superstores makes, again, a ton of sense. He's been 38 years in the business. and he's a retailer by heart and he's already now started to implement some of the new thinking and giving more value to our customers in that segment as well. So yes, it was something that I discussed with the Chairman very early and agreed that it was a good thing to do.
Okay. Just moving on to the Maxi conversions. Obviously, the indications are it's been very successful and continuing with that and probably likely going across Canada as well. When the first tranche we're converting underperforming stores, should we expect a similar level of performance as you continue to roll out these Maxi conversions? And how successful do you think these conversions will be in other parts of Canada?
Let me just talk about Quebec for a second. Like obviously, when we get to the tail end of the conversions, we're sort of getting to our stores that are not losing as much money as before. So from a profitability, it's a higher hurdle. But having said all that, the lift in sales we've been experiencing with those conversions continues to be quite significant. And so therefore, net-net, as an organization, we're definitely winning. So that is giving us the confidence to consider doing this beyond Quebec, and that's what the teams are thinking about right now.
Okay. And maybe just one on Connected Healthcare. And how high up the list of priorities is evolving Connected Healthcare? And when should we think of that meaningfully taking shape in terms of us understanding what the proposition has become at Loblaw?
Yes. I think it continues to play a big role for Shoppers. So you should think about it as being extremely important for us. And we are continuing to, again, see great performance on Connected Healthcare. So it's an important strategic pillar for us.
Can you give me some examples of what are the major planks in Connected Healthcare?
Lifemark acquisition is Connected Healthcare, like you look at something that's complementary to our business. And we look at the performance of Lifemark this year, and we're starting to be excited, okay? Like we have a new leader running the business, and she's doing a great job both on top line and bottom line. So that's a good example of a business that's adding to the roster of what Shoppers is offering. And then it's going to be -- it's all the other initiatives that Shoppers does that brings everything together that is going to just drive the sort of the growth of health care in general, of which Shoppers is part of.
Yes. And we now have 320 Lifemark clinics in our portfolio. So it is becoming significant. And then, of course, our future pharmacy. So we have invested in 4 future pharmacy locations in Q4 and now totaling of 6 locations. As you probably remember, the future pharmacies is a full redesign of dispensary with a waiting room, it's digital screens especially of Loblaw's and it's built to include consultation rooms that enable them to function like pharmacy clinic. So we're on it.
Okay. And the items like QHX and enabling doctors, is that still high in the priority list enabling doctors to send scripts and get their information on digitize, is that still a focus or?
Yes, that is still happening in terms of the scale of this versus what we just talked about. It's not as significant. What we just talked about is going to be what's going to drive the whole Shoppers Drug Mart ecosystem of businesses.
Our next question comes from Michael Van Aelst from TD Securities.
You've covered a lot, but I wanted to go back to the consumer health a little bit and -- it certainly seems like the industry overall is seeing lower tonnage. Have you seen that level off at all on a sequential basis. Are people -- have consumers got to the point where they can't really cut too much in terms of the amount of calories they intake?
No, we don't see that. And we believe it will be more of the same as last year. So a customer that will still I think, be at the same level as last year. But again, they will buy cheaper product, they will buy more into the promotion, they will buy more into a control brand and seeking into discount.
Yes, Mike, specifically, the overall tonnage in Q4 was essentially flat, okay? And when you look at what we were cycling, that's actually pretty good, okay? Because last year in Q4, we were heavily invested. But it's a tale of 2 stories like in discount, like tonnage is top. And in market, it's down a bit. So that's what we're seeing right now. But overall, organization, it's more or less flat.
And do you believe you're gaining share? And so in other words, tonnage for the industry is down?
Yes. We're definitely gaining share in discount. And in market like the whole conventional segment is losing share, but we're holding our own versus our peers. That's how you should think about this.
Okay. And the trade down that we see happening to private label, we all know it's normally margin accretive. Is that margin upside? Is that still holding true even as you try to hold prices lower?
I think you should see that as being neutral because its customers are trading down to some of our known and they are buying products at a lower price but with a higher margin which in control is general. So the penny profit would be the same. So it's absolutely fine for us.
Yes. no name continues to grow faster, okay? But it's not -- it's slowing. It's slowing. Like we saw like no name spike a lot, especially last year. It's still running higher than normal, but you can see the growth slowly inching back down as national brand growth starts to slowly inch back up. I think that's probably the best way to characterize this.
Yes. So I don't know if you have crystal ball or not, but wage growth is expected to grow faster than inflation this year. If that happens, is that enough, do you think, to see and improving consumer health? Or do you think there's -- that the hangover is going to be there from all this inflation going to be there for into 2025?
No, I think it will definitely help. So customers are getting more money to spend. Of course, that will help. But whether it's enough, it's too difficult to say.
Okay. And just finally on e-commerce. Can you give us an idea what the penetration is now? You should get that at the end of the year? And then how does that -- how does your performance differ in terms of the growth? How does that 15% breakdown between food and drug?
Yes. No. So it is the food part that's growing, and it's good for us and it's good for our customers because we are helping a lot of customers to light. So when they have small kids, they are buying more into our food offering and is close to 6% penetration. And as we stated, we have $2.3 billion total sales, but that's including Shoppers as well. And we talk about the food only. It's, of course, a little bit less, but we are growing ahead of the physical stores like a little bit more than double.
We're seeing a slight increase in penetration as the year progressed. And I'd say, as we said in our remarks, like where the growth in food is coming more -- it's on the delivery part. So that's where the big chunk of the growth is coming.
Yes. And the split now is 60% pickup and 40% delivery.
[Operator Instructions] The next question comes from Chris Li from Desjardins Securities.
I know you've kind of answered this in your opening remarks and some questions to the peers as well. But I just want to ask again, given your extensive experience in grocery, especially in discount, what do you see as some of the greatest opportunities in terms of leveraging your experience to sort of enhance Loblaw's value proposition?
No, thanks for that. I think my experience actually is both in hypermarket, supermarket and in discount and yes, in my previous company, our discount penetration was just over 50%. So I think there's a lot of learnings that we can take from Europe. But -- but as I get to know this business here in Canada, I also see that a lot of learnings that if I was to go back, which I'm not, then there's a lot of learnings that I could take from our hard discount format here.
So I think that we have the strongest hard discount format in both Maxi and No Frills in Canada. The way that we prioritize the fresh, the produce, the meat, I think that's excellent. And yes, and then learnings, yes, just a simple thing as shelf-ready packaging. So if you go to Aldi and Lidl, you will see that's 100% implemented. And if you go to our stores, we may be 10%, 15%. So that's just one example. So we have several examples and several things that we are working with, where we can both take cost out, but also other examples where we can give more value to our customers. So it's good. And I learn a lot, and hopefully, I can contribute a little bit with my experience.
Great. And then Richard, I'm just wondering, for your high single-digit EPS growth for the full year, just on a quarter-to-quarter basis, can we expect kind of similar high single-digit kind of spread out through consistently through the quarters? Or do you expect to be skewed to one period over the other?
Yes. Very happy you asked that question, Chris. So actually, when you look at our plan, like it's actually very, very stable for every quarter. So our plan, the way it's laid out, it should be the same number for every quarter. So in reality, it's probably going to be exactly that, but that's what the plan contemplates. So there's no spikes in first year or first half or second half. It's sort of stable throughout the year.
Okay. That's helpful. And then -- and maybe just one on Shoppers. Richard, I think in the past, you've said that Shoppers accounted for about 40% of retail EBITDA. I'm just wondering, do you have an updated number now what percentage of Shoppers for EBITDA?
It's in the mid-40s now.
Okay, in the mid-40s. Okay. So if I just -- and maybe we can take this offline afterwards. But if I just do the quick math and based on the revenues for food and drug that you do disclose publicly, based on that 45% contribution and that would suggest your Shoppers EBITDA margin is more like 17% versus 8% or 9% for food implied. I guess my question is has that margin gap widened over time? And if so, what has been the drivers and do expect Shoppers margin to continue to grow given all the initiatives that you've noted that are still to come?
Yes, Chris, let's take that one off-line.
Okay. And last one just on Shoppers again. I think this is like the second and third quarter in a roll where you call out specialty drugs as being a driver. Just wondering if you can size up for us the -- what is -- how much of a contribution is that helping your comps just on the specialty drugs alone?
It's a relatively new phenomenon, okay? But the average value of these drugs is extremely high. And so it's a driver of average script value. And demand is also very high. And the issue we're facing is we don't have enough supply. That's the issue we're facing. So we don't know what's the size of this yet because we just can't meet demand for the moment.
Yes, especially Ozempic has been short in deliveries.
There appear to be no further questions. I will turn the conference back to your speakers for any closing comments.
Great. Thanks, everybody, for your time this morning. And if you have any follow-up questions, give me a shot or drop me an e-mail. And finally, please mark your calendars for Wednesday, May 1, when we'll be releasing our Q1 results. Thanks, and have a great day.
Thank you. This does conclude today's conference call. Thank you all for attending. You may now disconnect your lines.